Article (Scientific journals)
Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies
Donis, Nathalie; Oury, Cécile; MOONEN, Marie et al.
2018In Expert Opinion on Pharmacotherapy, 19 (5), p. 431-442
Peer Reviewed verified by ORBi
 

Files


Full Text
donis2018.pdf
Publisher postprint (1.33 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Cancer
Abstract :
[en] Introduction: Available data indicate that survivors of breast cancer and Hodgkin lymphoma who received mediastinal radiotherapy are at increased risk of developing radiation-induced cardiovascular diseases (RICVD) one or two decades after treatment. Although the risk with modern radiation treatment is likely to be lower in these patient groups, cardiotoxicity is still observed in a subset of patients. In addition, radiation-associated cardiovascular complications can, in the future, extend to other groups of cancer patients who are treated for tumors that are localized near the heart. Areas covered: The authors briefly describe the most commonly observed types of RICVD. They then present an overview of preclinical animal and cellular models that have been used to investigate the mechanisms underlying RICVD pathophysiology. The beneficial effects of available drugs, and potential targets for new molecules are also reported. Expert opinion: There is a need to develop cardio-oncological programs and pharmacotherapies specifically targeting RICVD. Beyond statins, ACE inhibitors, anti-inflammatory and antioxidant agents, preclinical studies indicate that TGFβ receptor I inhibitors, Sestrin2 inducers, recombinant neuregulin-1 and miR-21 inhibitors might represent novel promising strategies. In order to properly determine the optimal therapeutic index for these molecules, in vivo models combining cancer and RICVD should be envisioned. © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Donis, Nathalie ;  Université de Liège - ULiège > GIGA-Research
Oury, Cécile  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences
MOONEN, Marie ;  Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie
Lancellotti, Patrizio  ;  Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Language :
English
Title :
Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies
Publication date :
2018
Journal title :
Expert Opinion on Pharmacotherapy
ISSN :
1465-6566
eISSN :
1744-7666
Publisher :
Taylor and Francis Ltd
Volume :
19
Issue :
5
Pages :
431-442
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 21 June 2018

Statistics


Number of views
71 (9 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
16
Scopus citations®
without self-citations
14
OpenCitations
 
14

Bibliography


Similar publications



Contact ORBi